ПОВОЛЖСКИЙ ОНКОЛОГИЧЕСКИЙ ВЕСТНИК 1( 28)’ 2017
Loop // Protein Sci.— 2016.— 25( 2).— P. 499-510.
19. Schuliga M. The inflammatory actions of coagulant and fibrinolytic proteases in disease // Mediators Inflamm.— 2015.— P. 4376-95.
20. Shoji F., Yano T., Yoshino I., et al. The dynamics and clinical significance of alpha 2 plasmin inhibitor-plasmin complex and thrombin-antithrombin complex in postoperative pleural effusion following a pulmonary lobectomy // Surg. Today.— 2009.— 39( 4).— P. 320-5. PMID: 19319640 DOI: 10.1007 / s00595-008-3865-9
21. Suh Y. S., Yu J., Kim B. C., et al. Overexpression of Plasminogen Activator Inhibitor-1 in Advanced Gastric Cancer with Aggressive Lymph Node Metastasis // Cancer Res. Treat.— 2015.— 47( 4).— P. 718-26. DOI: 10.4143 / crt. 2014.064
22. Tang L., Han X. The urokinase plasminogen activator system in breast cancer invasion and metastasis // Biomedicine and Pharmacotherapy.— 2013.— 67( 2).— P. 179-182. PMID: 23201006 DOI: 10.1016 / j. biopha. 2012.10.003
23. Thomson C. A., Crane T. E., Miller A., et al. A randomized trial of diet and physical activity in women treated for stage II-IV ovarian cancer: Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced
Survival( LIVES): An NRG Oncology / Gynecologic Oncology Group( GOG-225) Study. Contemp. Clin. Trials. 2016, Jul 6; pii: S. 1551-7144( 16): 30105-7. [ Epub ahead of print ] PMID: 27394382 DOI: 10.1016 / j. cct. 2016.07.005
24. Wang C. Y., Chen C. L., Tseng Y. L., et al. Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and-independent mechanisms // J. Biol. Chem.— 2012.— 287.— P. 32512-24. doi: 10.1074 / jbc. M112.351957. [ PMC free article ] [ PubMed ] [ Cross Ref ]
25. Witzel I., Milde-Langosch K., Schmidt M., et al. Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer // Onco. Targets Ther.— 2014. Nov. 28.— 7.— P. 2205-13. DOI: 10.2147 / OTT. S65344. eCollection 2014.
26. Yamashita D., Kondo T., Ohue S., et al. miR340 suppresses the stem-like cell function of gliomainitiating cells by targeting tissue plasminogen activator // Cancer Res.— 2015.— 75( 6).— P. 1123-33.
48 Клинические исследования и опыт в онкологии